3.0.0 2057 2023-01-11T13:37:55Z 2023-01-11T13:37:55Z Senate S 2017-11-01 115 ssga00 Homeland Security and Governmental Affairs Committee Senate Standing Referred to 2017-11-01T21:22:26Z 2017-11-01 ssga00 Homeland Security and Governmental Affairs Committee Senate Read twice and referred to the Committee on Homeland Security and Governmental Affairs. IntroReferral 2017-11-01 Introduced in Senate IntroReferral 10000 9 Library of Congress B001230 Sen. Baldwin, Tammy [D-WI] Tammy Baldwin D WI N F000062 Sen. Feinstein, Dianne [D-CA] Dianne Feinstein D CA 2017-11-01 True H001075 Sen. Harris, Kamala D. [D-CA] Kamala Harris D CA D. 2017-11-01 True H001076 Sen. Hassan, Margaret Wood [D-NH] Maggie Hassan D NH 2017-11-01 True M000133 Sen. Markey, Edward J. [D-MA] Edward Markey D MA J. 2017-11-01 True S001181 Sen. Shaheen, Jeanne [D-NH] Jeanne Shaheen D NH 2017-11-01 True U000039 Sen. Udall, Tom [D-NM] TOM UDALL D NM 2017-11-01 True M001183 Sen. Manchin, Joe, III [D-WV] Joseph Manchin D WV 2017-11-08 False W000802 Sen. Whitehouse, Sheldon [D-RI] Sheldon Whitehouse D RI 2017-11-16 False Government Operations and Politics Government Operations and Politics 00 2017-11-01 Introduced in Senate 2019-09-05T20:05:08Z Pharmaceutical Regulation Conflict of Interest Act

This bill amends the Ethics in Government Act of 1978 to prohibit a pharmaceutical regulator from using his or her position as regulator to influence any matter that provides a direct or substantial pecuniary benefit to a former employer or client. The position of pharmaceutical regulator refers to any officer or employee occupying a supervisory position within the Drug Enforcement Administration or the Food and Drug Administration.

The bill also prohibits such a pharmaceutical regulator from participating in matters involving an individual or entity with whom the pharmaceutical regulator is negotiating future employment.

The bill expands restrictions on lobbying by such pharmaceutical regulators following separation from employment with a pharmaceutical regulatory agency.

]]> Pharmaceutical Regulation Conflict of Interest Act Display Title Pharmaceutical Regulation Conflict of Interest Act Short Titles as Introduced Pharmaceutical Regulation Conflict of Interest Act Official Title as Introduced A bill to prevent conflicts of interest that stem from the revolving door that raises concerns about the independence of pharmaceutical regulators. Introduced in Senate 2017-11-01T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115s2057is/xml/BILLS-115s2057is.xml 2017-11-01 Read twice and referred to the Committee on Homeland Security and Governmental Affairs. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.